IN-DATE
GEM2756-FC-SD: Synovis GEM FlowCoupler, 4.0mm
Sign in to add this product to your favorites!
| Price: | $299.99 $150.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 2 box of 1 |
| Expiration: | 09-2026 |
Additional Details
Synovis GEM FlowCoupler
The FLOW COUPLER Device is a single use, implantable device that is intended to be used in the end-to-end anastomosis of veins and arteries normally encountered in microsurgical and vascular reconstructive procedures. The FLOW COUPLER Device includes a pair of permanently implanted rings which secure the anastomosis and a removable Doppler probe that is press-fit onto one of the rings. The FLOW COUPLER Device and System is contraindicated for use in the central circulatory system.
AccessGUDID Info
- FDA Product Code: DPW
- FDA Product Code Name: FLOWMETER, BLOOD, CARDIOVASCULAR
- FDA Product Code: MVR
- FDA Product Code Name: Device,anastomotic,microvascular
- GMDN Term Code: 61382
- GMDN Term Name: Vascular anastomosis coupler, Doppler
- GMDN Term Description: An implantable device intended to be used to permanently join vascular structures (blood vessels) that includes an attached ultrasound (Doppler) probe for measuring blood flow through the anastomosis; it is typically used during microvascular surgery. It consists of two ring-shaped components over which the ends of the vessels are everted and held in place by pins; the rings are approximated using a dedicated device to create the anastomosis. The probe is connected to an external monitor and used to confirm vessel patency during and after the procedure for up to 14 days before it is removed.
Manufacturer
Baxter provides a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
